Gemma Lasseter
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Palliative Care and End-of-Life Issues 5
- Streptococcal Infections and Treatments 4
-
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Cliodna McNulty (13 shared papers)Sarah Purdy (5 shared papers)Lesley Wye (5 shared papers)John Percival (4 shared papers)Lorna Duncan (4 shared papers)Rebecca Howell‐Jones (2 shared papers)André Charlett (2 shared papers)Mike Thomas (1 shared paper)
- Journals
- Health Technology Assessment (3 papers)BMC Public Health (2 papers)British Journal of General Practice (2 papers)Family Practice (2 papers)BMJ Supportive & Palliative Care (1 paper)
- Partner nations
- United KingdomMaldivesQatar
In The Last Decade
Gemma Lasseter
29 papers receiving 489 citations
Peers
Comparison fields: 5 of 78
- Applied Microbiology and Biotechnology 52
- Clinical Biochemistry 43
- Public Health, Environmental and Occupational Health 146
- Health 36
- Infectious Diseases 70
Countries citing papers authored by Gemma Lasseter
This map shows the geographic impact of Gemma Lasseter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Lasseter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Lasseter more than expected).
Fields of papers citing papers by Gemma Lasseter
This network shows the impact of papers produced by Gemma Lasseter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Lasseter. The network helps show where Gemma Lasseter may publish in the future.
Co-authors
The 25 scholars most cited alongside Gemma Lasseter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 55 | |
| 2 | 2012 | 54 | |
| 3 | 2014 | 46 | |
| 4 | 2021 | 43 | |
| 5 | 2014 | 40 | |
| 6 | 2014 | 30 | |
| 7 | 2022 | 28 | |
| 8 | 2010 | 27 | |
| 9 | 2022 | 24 | |
| 10 | 2009 | 24 | |
| 11 | 2016 | 21 | |
| 12 | 2013 | 14 | |
| 13 | 2023 | 13 | |
| 14 | 2012 | 12 | |
| 15 | 2024 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2020 | 8 | |
| 18 | 2011 | 7 | |
| 19 | 2018 | 7 | |
| 20 | 2013 | 7 |
About Gemma Lasseter
Gemma Lasseter is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases, General Health Professions, Clinical Psychology and Epidemiology, having authored 30 papers that have together received 509 indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (5 papers), Streptococcal Infections and Treatments (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Vaccine Coverage and Hesitancy (2 papers), Plant Pathogens and Fungal Diseases (2 papers), Fungal Infections and Studies (2 papers), Nail Diseases and Treatments (2 papers) and Healthcare Decision-Making and Restraints (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (52 citations), Clinical Biochemistry (43 citations), Public Health, Environmental and Occupational Health (146 citations), Health (36 citations) and Infectious Diseases (70 citations). Gemma Lasseter has collaborated with scholars based in United Kingdom, Maldives and Qatar. Frequent co-authors include Cliodna McNulty, Sarah Purdy, Lesley Wye, John Percival, Lorna Duncan, Rebecca Howell‐Jones, André Charlett, Mike Thomas, Ian Shaw and T. Nichols. Their work appears in journals such as Health Technology Assessment, BMC Public Health, British Journal of General Practice, Family Practice and BMJ Supportive & Palliative Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.